Sponsored Links
| Fraunhofer USA CMB Announces Positive Phase 1 Interim Results For Its Plant-Produced H1N1 Influenza Vaccine |
 |
 |
 |
| Medical News - Flu Cold SARS | |||
|
Fraunhofer USA Center for Molecular Biotechnology (CMB), a not-for-profit, Delaware-based organization focused on developing a proprietary plant-based protein production platform and its applications in vaccine and therapeutic fields, today announced positive interim results from the first human trial of plant-produced H1N1 influenza vaccine (HAC1) that began on September 13, 2010... Read more: Flu / Cold / SARS News From Medical News Today
|